FDA Transparency Task Force Unveils Draft Proposals on Agency Disclosure Policies Public comment invited on 21 draft proposals

The U.S. Food and Drug Administration's Transparency Task Force today released 21 draft proposals for public comment on public disclosure policies aimed at helping consumers, stakeholders, and others understand how the agency operates and makes decisions. The Transparency Task Force will review the comments and decide which proposals to recommend for implementation.